WO2010145921A2 - Compositions cosmétiques contenant des sels d'argent sélectionnés - Google Patents

Compositions cosmétiques contenant des sels d'argent sélectionnés Download PDF

Info

Publication number
WO2010145921A2
WO2010145921A2 PCT/EP2010/057207 EP2010057207W WO2010145921A2 WO 2010145921 A2 WO2010145921 A2 WO 2010145921A2 EP 2010057207 W EP2010057207 W EP 2010057207W WO 2010145921 A2 WO2010145921 A2 WO 2010145921A2
Authority
WO
WIPO (PCT)
Prior art keywords
silver
aluminum
oil
preferred
weight
Prior art date
Application number
PCT/EP2010/057207
Other languages
German (de)
English (en)
Other versions
WO2010145921A3 (fr
Inventor
Bernhard Banowski
Imme Breuer
Original Assignee
Henkel Ag & Co. Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Ag & Co. Kgaa filed Critical Henkel Ag & Co. Kgaa
Publication of WO2010145921A2 publication Critical patent/WO2010145921A2/fr
Publication of WO2010145921A3 publication Critical patent/WO2010145921A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/0229—Sticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A61K2800/31—Anhydrous

Definitions

  • the present application relates to anhydrous cosmetic or dermatological preparations, in particular antiperspirants, which contain silver salts of selected organic acids.
  • aqueous colloidal silver solutions are either liquid dispersions of elemental silver or liquid dispersions of complex sparingly soluble silver compounds.
  • the water-dispersible starting materials then contain silver ions only in traces.
  • WO 2006029213 A1 describes antimicrobial silver citrate compounds. These are commercially available under TINOSAN ® SDC in aqueous citric acid, a tricarboxylic acid, stabilized silver compounds. The preparation of these compounds via an electrochemical process is described in EP 1041879 A1.
  • TINOSAN ® SDC contains electrolytically generated silver ions (Ag + ) and there is no colloidal silver in the mixture.
  • the TINOSAN described in the publications WO 2006029213 A1 and EP 1041879 A1 ® SDC may be used in cosmetic, in aqueous and / or emulsion based composition and with various additives.
  • deodorants and antiperspirants are disclosed which contain TINOSAN ® SDC.
  • DE 202008014407 U1 proposes to solve these problems to use one or more thickeners selected from the group of phyllosilicates and / or talc, which are usually gelled with a small amount of water or polar solvent and according to DE 202008014407 U1 instead with Tinosan SDC and possibly further water are gelled.
  • means may be provided, comprising (wt .-% of the TINOSAN ® SDC plus additional 5 wt .-% of other sources than 5) may contain up to 10 wt .-% water.
  • anhydrous cosmetic or dermatological preparation containing at least one silver salt of an organic acid selected from aliphatic mono- or dicarboxylic acids having an even number of carbon atoms which may be substituted with one or more hydroxy groups and aromatic carboxylic acids , further one or more thickeners selected from the group of layered silicates and / or talc, one or more antiperspirant active ingredients and perfume.
  • Anhydrous preparation means that additional water may be present up to a proportion of about 3 wt .-%, based on the total mass of the preparation.
  • Anhydrous is preferably a proportion of not more than 2% by weight, in particular 0% by weight, of water, based on the total mass of the preparation.
  • the thickeners are preferably selected from the group of phyllosilicates and fillers, such as talc.
  • Phyllosilicates are polymeric crystalline sodium disilicates.
  • Phyllosilicates preferred according to the invention are selected from clay minerals, such as bentonite, montmorillonite, nontronite, hectorite, saponite, sauconite, beidellite, allevardite, illite, halloysite, attapulgite and / or sepiolite. Disteardimonium is hectorite.
  • Another thickener according to the invention is talc, talc or talcum, preferably talcum with the INCI name TaIc, E553b.
  • Talc is a natural, widespread Mag- nesiumsilicat Mg 3 E (OH) 2 ZSi 4 O 10] or 3 ⁇ 4 MgO SiO 2 H 2 O, which the three-layer (2: 1) has Caten Phyllosili- whose denser aggregates called soapstone.
  • the thickening agents are preferably present in a proportion of 0.5 to 10% by weight, preferably 1 to 7% by weight, more preferably 2 to 6% by weight, most preferably 3 to 5% by weight .-%, in each case based on the total mass of the preparation or active ingredient mixture.
  • these amounts refer to the weight of the propellant-free composition.
  • Cosmetic antiperspirants or deodorants serve to eliminate body odor that results when the odorless fresh sweat is decomposed by microorganisms.
  • the usual cosmetic deodorants are based on different active principles.
  • antiperspirants can be reduced by astringents - predominantly aluminum salts, such as aluminum hydroxychloride (aluminum chlorohydrate (ACH), which may be activated (AACH)) or aluminum zirconium salts (AZG) - the formation of perspiration.
  • astringents such as aluminum hydroxychloride (aluminum chlorohydrate (ACH), which may be activated (AACH)) or aluminum zirconium salts (AZG) - the formation of perspiration.
  • ACH aluminum hydroxychloride
  • AACH aluminum zirconium salts
  • antimicrobial silver salts of an organic acid selected from aliphatic mono- or dicarboxylic acids having an even number of carbon atoms which may be substituted with one or more hydroxy groups, and aromatic carboxylic acids in cosmetic antiperspirants, the bacterial flora on the Skin be reduced.
  • the odor-causing microorganisms are effectively reduced.
  • the sweat flow itself is not affected by this, in the ideal case only the microbial decomposition of the sweat is temporarily stopped.
  • compositions according to the invention contain at least one antiperspirant active substance.
  • Preferred antiperspirant active ingredients are selected from the water-soluble astringent inorganic and organic salts of aluminum, zirconium and zinc or any desired mixtures of these salts.
  • solubility of at least 5 wt .-% at 20 0 C is understood according to the invention, solubility in water, that is, amounts of at least 5 g of the antiperspirant active ingredient in 95 g of water are soluble at 20 0 C.
  • antiperspirant active ingredients are selected from aluminum chlorohydrate, in particular aluminum chlorohydrate having the general formula [Al 2 (OH) 5 Cl. 1-6 H 2 O] n , preferably [Al 2 (OH) 5 Cl. 2-3 H 2 O. ] n , which may be in non-activated or in activated (depolymerized) form, and aluminum chlorohydrate having the general formula [Al 2 (OH) 4 Cl 2 ⁇ 1-6 H 2 O] n , preferably [Al 2 (OH) 4 CI 2 ⁇ 2-3 H 2 O] n , which may be in unactivated or activated (depolymerized) form.
  • the preparation of preferred antiperspirant agents is disclosed, for example, in US 3887692, US 3904741, US 4359456, GB 2048229 and GB 1347950.
  • aluminum sesquichlorohydrate aluminum dichlorohydrate, aluminum chlorohydrex-propylene glycol (PG) or aluminum chlorohydrex polyethylene glycol (PEG), aluminum or aluminum zirconium glycol complexes, e.g. Aluminum or aluminum zirconium propylene glycol complexes, aluminum sesquichlorohydrex PG or aluminum sesquichlorohydrex PEG, aluminum PG dichlorohydrex or aluminum PEG dichlorohydrex, aluminum hydroxide further selected from the aluminum zirconium chlorohydrates such as aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium pentachlorohydrate, aluminum zirconium octachlorohydrate, aluminum-zirconium chlorohydrate glycine complexes, such as Aluminiumzirco- niumtrichlorohydrexglycin, Aluminiumzirconiumtetrachlorohydrexglycin, Aluminiumzirconium- pentach
  • Antiperspirant active ingredients which are particularly preferred according to the invention are selected from what are known as “activated” aluminum and aluminum zirconium salts, which are also referred to as “enhanced activity” as antiperspirant active ingredients. Such agents are known in the art and are also commercially available. Their preparation is disclosed, for example, in GB 2048229, US 4775528 and US 6010688.
  • Activated aluminum and aluminum-zirconium salts are typically produced by heat-treating a relatively dilute solution of the salt (e.g., about 10% by weight of salt) to increase its HPLC peak 4-to-peak 3 area ratio. The activated salt can then be dried to a powder, in particular spray-dried. In addition to the spray drying z. B. also suitable for drum drying.
  • Activated aluminum and aluminum zirconium salts typically have an HPLC peak 4 to peak 3 area ratio of at least 0.4, preferably at least 0.7, more preferably at least 0.9, with at least 70% of the aluminum attributable to these peaks , Activated aluminum and aluminum zirconium salts do not necessarily have to be used as a spray-dried powder.
  • Antiperspirant active ingredients which are likewise preferred according to the invention are nonaqueous solutions or solubilisates of an activated aluminum or aluminum zirconium antiperspirant salt, for example according to US 6010688, by adding an effective amount of a polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups , preferably propylene glycol, sorbitol and pentaerythritol, against the loss of activation against the rapid degradation of the HPLC peak 4: peak 3 area ratio of the salt are stabilized.
  • a polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups preferably propylene glycol, sorbitol and pentaerythritol
  • compositions containing by weight 18-45% by weight of an activated aluminum or aluminum zirconium salt, 55-82% by weight of at least one anhydrous polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups, preferably propylene glycol, butylene glycol, diethylene glycol, dipropylene glycol, glycerol, sorbitol and pentaerythritol, more preferably propylene glycol.
  • Propylene glycol, propylene glycol / sorbitol mixtures and propylene glycol / pentaerythritol mixtures are preferred such alcohols.
  • Such inventively preferred complexes of an activated antiperspirant aluminum or aluminum zirconium salt with a polyhydric alcohol are, for. As disclosed in US 5643558 and US 6245325.
  • antiperspirant active substances are basic calcium aluminum salts, as disclosed, for example, in US Pat. No. 2,571,030. These salts are prepared by reacting calcium carbonate with aluminum chlorhydroxide or aluminum chloride and aluminum powder or by adding calcium chloride dihydrate to aluminum chlorhydroxide.
  • Other preferred antiperspirant actives are aluminum-zirconium complexes as disclosed, for example, in US Pat. No. 4,017,599, which are buffered with salts of amino acids, in particular with alkali metal and alkaline earth glycinates.
  • activated aluminum or aluminum zirconium salts such as disclosed in US 6,245,325 or US 6042816, containing 5-78% by weight (USP) of an activated antiperspirant aluminum or aluminum zirconium salt, an amino acid or hydroxyalkanoic acid in an amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20 and preferably 1: 1 to 1:10 and a water-soluble calcium salt in such an amount as to provide Ca: (AI + Zr) weight ratio of 1: 1-1: 28 and preferably 1: 2-1: 25.
  • USP activated aluminum or aluminum zirconium salts
  • an amino acid or hydroxyalkanoic acid in an amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20 and preferably 1: 1 to 1:10
  • a water-soluble calcium salt in such an amount as to provide Ca: (AI + Zr) weight
  • Particularly preferred solid activated antiperspirant salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum zirconium salt and 1-16% by weight. %, preferably 4-13% by weight molecularly bound water (water of hydration), furthermore sufficient water-soluble calcium salt, that the Ca: (Al + Zr) weight ratio is 1: 1-1: 28, preferably 1: 2-1: 25, is and so much amino acid that the amino acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • USP 48-78% by weight
  • % preferably 66-75% by weight of an activated aluminum or aluminum zirconium salt and 1-16% by weight.
  • % preferably 4-13% by weight molecularly bound water (water of hydration), furthermore sufficient water-soluble calcium salt, that the Ca: (Al + Zr) weight ratio is 1
  • solid antiperspirant activated salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66-75 wt .-% of an activated aluminum or aluminum zirconium salt and 1-16% by weight, preferably 4-13 wt .-% molecularly bound water (water of hydration), further so much water-soluble calcium salt that the Ca: (Al + Zr) weight ratio 1: 1-1: 28, preferably 1: 2-1: 25, and so much glycine that the glycine to (Al + Zr) - weight ratio 2: 1-1: 20, preferably 1: 1 - 1: 10, is.
  • solid antiperspirant activated salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum zirconium salt and 1-16% by weight. %, preferably 4-13% by weight of molecularly bound water, furthermore sufficient water-soluble calcium salt, that the Ca: (Al + Zr) weight ratio is 1: 1-1: 28, preferably 1: 2-1: 25, and so much hydroxyalkanoic acid that the hydroxyalkanoic acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • Preferred water-soluble calcium salts for the stabilization of antiperspirant salts are selected from calcium chloride, calcium bromide, calcium nitrate, calcium citrate, calcium formate, calcium acetate, calcium gluconate, calcium ascorbate, calcium lactate, calcium glycinate, calcium carbonate, calcium sulfate, calcium hydroxide, and mixtures thereof.
  • Preferred amino acids for the stabilization of the antiperspirant salts are selected from glycine, alanine, leucine, isoleucine, ⁇ -alanine, valine, cysteine, serine, tryptophan, phenylalanine, methionine, ⁇ -amino-n-butanoic acid and ⁇ -amino-n-butanoic acid and the salts thereof, each in the d-form, the I-form and the dl-form; Glycine is particularly preferred.
  • Preferred hydroxyalkanoic acids for the stabilization of the antiperspirant salts are selected from glycolic acid and lactic acid.
  • activated aluminum or aluminum zirconium salts such as disclosed in US 6902723, containing 5-78% by weight (USP) of an activated antiperspirant aluminum or aluminum zirconium salt, an amino acid or hydroxyalkanoic acid in one Amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20, and preferably 1: 1 to 1:10, and a water-soluble strontium salt in such an amount to give a Sr :( Al + Zr) - weight ratio of 1: 1 - 1: 28 and preferably 1: 2 - 1: 25 provide.
  • US 6902723 containing 5-78% by weight (USP) of an activated antiperspirant aluminum or aluminum zirconium salt, an amino acid or hydroxyalkanoic acid in one Amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20, and preferably 1: 1 to 1:1
  • Particularly preferred solid antiperspirant activated salt compositions contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4 - 13 wt .-% molecularly bound water, further enough so much water-soluble strontium salt that the Sr: (AI + Zr) weight ratio 1: 1 - 1: 28, preferably 1: 2 - 1: 25, and so much amino acid the amino acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • solid antiperspirant activated salt compositions for example according to US 6902723, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4 to 13 wt .-% molecularly bound water, further so much water-soluble strontium salt, that the Sr: (Al + Zr) weight ratio is 1: 1-1: 28, preferably 1: 2-1: 25, and so much glycine that the glycine is (Al + Zr) weight ratio 2: 1-1: 20 , preferably 1: 1 - 1:10.
  • solid antiperspirant activated salt compositions for example according to US 6902723, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4 to 13% by weight of molecularly bound water, furthermore sufficient water-soluble strontium salt that the Sr: (Al + Zr) weight ratio is 1: 1 to 1:28, preferably 1: 2 to 1:25, and as much hydroxyl-containing alkanoic acid that the hydroxyalkanoic acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • activated aluminum salts are those of the general formula Al 2 (OH) 6 . a Xa, wherein X is Cl, Br, I or NO 3 and "a" is a value of 0.3 to 5, preferably from 0.8 to 2.5 and particularly preferably 1 to 2, so that the molar ratio of Al X is 0.9: 1 to 2.1: 1, as disclosed, for example, in US 6074632.
  • These salts generally associate some hydration water, typically 1 to 6 moles of water per mole of salt.
  • Particularly preferred is aluminum chlorohydrate (ie, X is Cl in the aforementioned formula) and especially 5/6 basic aluminum chlorohydrate wherein "a” is 1 such that the molar ratio of aluminum to chlorine is 1.9: 1 to 2.1: 1 ,
  • Preferred activated aluminum-zirconium salts are those which are mixtures or complexes of the aluminum salts described above with zirconium salts of the formula ZrO (OH) 2 _ pb b represent Y, wherein Y is Cl, Br, I, NO 3 or SO 4, b is a rational number from 0.8 to 2 and p is the valence of Y, as disclosed, for example, in US 6074632.
  • the zirconium salts also typically associate some hydration water associatively, typically 1 to 7 moles of water per mole of salt.
  • the zirconium salt is zirconyl hydroxychloride having the formula ZrO (OH) 2 -b Cl b , wherein b is a rational number of from 0.8 to 2, preferably from 1.0 to 1.9.
  • Preferred aluminum zirconium salts have a molar Al: Zr mole ratio of 2 to 10 and a metal: (X + Y) ratio of 0.73 to 2.1, preferably 0.9 to 1.5.
  • a particularly preferred salt is aluminum-zirconium chlorohydrate (ie, X and Y are Cl), which has a molar Al: Zr ratio of 2 to 10 and a molar metal: Cl ratio of 0.9 to 2.1.
  • the term aluminum-zirconium chlorohydrate includes the tri-, tetra-, penta- and octachlorohydrate forms.
  • the antiperspirant active ingredients can be present both in solubilized and in undissolved, suspended form.
  • the antiperspirant active ingredients are suspended in a water-immiscible carrier, it is preferred for reasons of product stability that the active ingredient particles have a number-average particle size of 0.1-200 ⁇ m, preferably 1-50 ⁇ m, particularly preferably 3-20 ⁇ m and exceptionally preferably 5-10 ⁇ m.
  • Preferred active substance particles have a volume-average particle size of 0.2-220 .mu.m, preferably 3-60 .mu.m, more preferably 4-25 .mu.m and most preferably 10-15.5 .mu.m.
  • Preferred aluminum salts and aluminum zirconium salts have a molar metal-to-chloride ratio of 0.9-2.0, preferably 0.1-0.15, more preferably 1.1-1.5, even more preferably 1.3-3, 4, up.
  • Further preferred aluminum zirconium trichlorohydrates have the empirical formula Al 4 (OH) 10 Cl 2 .Zr (OH) Cl.
  • Aluminiumzirconiumtetrachlorohydrate have the empirical formula Al 4 (OH) 10 Cl 2 ZrCl ⁇ 2nd
  • Aluminiumzirconiumpentachlorohydrate have the empirical formula AI 8 (OH) 20 CI 6 ⁇ Zr (OH) Cl.
  • Aluminiumzirconiumoctachlorohydrate have the empirical formula AI 8 (OH) 18 CI 6 ⁇ Zr (OH) Cl.
  • water of hydration is associatively bound to these salts, typically 1-6 moles of water per mole of salt, corresponding to 1-30% by weight, preferably 4-13% by weight of water of hydration.
  • the preferred aluminum zirconium chlorohydrates are associated with an amino acid to prevent polymerization of the zirconium species during manufacture.
  • Preferred stabilizing amino acids are selected from glycine, alanine, leucine, isoleucine, ⁇ -alanine, cysteine, valine, serine, tryptophan, phenylalanine, methionine, ⁇ -amino-n-butanoic acid and ⁇ -amino-n-butanoic acid and the salts thereof, each in the d-form, the I-form and the dl-form; Glycine is particularly preferred.
  • the amino acid is contained in the salt in an amount of 1 to 3 moles, preferably 1 to 3 to 1.8 moles, per mole of zirconium.
  • the aforementioned aluminum-zirconium trichlorohydrates, aluminum-zirconium tetrachlorohydrates, aluminum-zirconium pentachlorohydrates and aluminum-zirconium octachlorohydrates are preferably present both as activated and unactivated as complexes with glycine.
  • Particularly preferred antiperspirant active substances are selected from activated aluminum-zirconium trichlorohydrex glycine, in particular activated aluminum-zirconium trichlorohydrex glycine with a water-free and glycine-free active substance (USP) of 69.5-88% by weight, preferably 72-85% by weight %, more preferably 77-80% by weight, in each case based on the raw material tel quel, of a molar metal: CI ratio of 0.9 to 1.5 and a molar Al: Zr ratio of 3.4. 3.8.
  • activated aluminum-zirconium trichlorohydrex glycine activated aluminum-zirconium trichlorohydrex glycine with a water-free and glycine-free active substance (USP) of 69.5-88% by weight, preferably 72-85% by weight %, more preferably 77-80% by weight, in each case based on the raw material tel quel, of a
  • antiperspirant active substances are selected from non-activated aluminum-zirconium trichlorohydrex glycines, in particular non-activated aluminum zirconium trichlorohydrex glycines with anhydrous and glycine-free active substance (USP) of 69.5-88% by weight, preferably 72 - 85 wt .-%, particularly preferably 77 - 80 wt .-%, each based on the raw material tel quel, a molar metal: CI ratio of 0.9 to 1, 5 and a molar Al: Zr ratio of 3 , 4 - 3,8.
  • USP anhydrous and glycine-free active substance
  • antiperspirant active substances are selected from activated aluminum-zirconium tetrachlorohydrex glycine, in particular activated aluminum-zirconium tetrachlorohydrex glycine with an anhydrous and glycine-free active substance (USP) of 72-88% by weight, preferably 77-85% by weight.
  • anhydrous and glycine-free active substance USP
  • antiperspirant active substances are selected from non-activated aluminum-zirconium tetrachlorohydrex glycine, in particular non-activated aluminum zirconium tetrachlorohydrex glycine with a water-free and glycine-free active substance (USP) of 72-88% by weight, preferably 77-85% by weight. -%, each based on the raw material tel quel, a molar metal: CI ratio of 0.9 to 1, 5 and a molar AI: Zr ratio of 3.4 - 3.8.
  • USP water-free and glycine-free active substance
  • antiperspirant active substances are selected from activated aluminum zirconium pentachlorohydrex glycine, in particular activated aluminum zirconium pentachlorohydrex glycine with a water-free and glycine-free active substance (USP) of 72-88% by weight, preferably 77-86% by weight. , particularly preferably 78-81, 5 wt .-%, each based on the raw material tel quel, a molar metal: CI ratio of 1, 51 to 2.0 and a molar Al: Zr ratio of 9.2 to 9 ,8th.
  • activated aluminum zirconium pentachlorohydrex glycine in particular activated aluminum zirconium pentachlorohydrex glycine with a water-free and glycine-free active substance (USP) of 72-88% by weight, preferably 77-86% by weight. , particularly preferably 78-81, 5 wt .-%, each based on the raw material tel quel,
  • antiperspirant active ingredients are selected from non-activated aluminum zirconium pentachlorohydrex glycine, in particular non-activated aluminum zirconium pentachlorohydrex glycine with a water-free and glycine-free active substance (USP) of 72-88 wt.%, Preferably 77-86 wt. %, more preferably 78-81.5% by weight, based in each case on the raw material tel quel, of a molar metal: CI ratio of 1.51 to 2.0 and a molar Al: Zr ratio of 9.2 - 9,8.
  • USP water-free and glycine-free active substance
  • Further preferred aluminum zirconium trichlorohydrex glycines have the empirical formula [Al 4 (OH) 10 Cl 2 .Zr (OH) Cl] .NH 2 CH 2 COOH.
  • Aluminum-zirconium tetrachlorohydrex glycine have the empirical formula [Al 4 (OH) 10 Cl 2 ⁇ ZrOCl 2] ⁇ NH 2 CH 2 COOH.
  • Aluminum zirconium pentachlorohydrex glycines have the empirical formula [Al 8 (OH) 20 Cl 4 .Zr (OH) Cl] .NH 2 CH 2 COOH.
  • Aluminum Zirconiumoctachlorohydrex Glycine have the empirical formula [Al 8 (OH) 18 Cl 6 ⁇ Zr (OH) CI] ⁇ NH 2 CH 2 COOH or [Al 8 (OH) 18 Cl 6 ⁇ ZrOCl 2] ⁇ NH 2 CH 2 COOH.
  • aluminum zirconium chlorohydrate-glycine salts which are stabilized with betaine ((CH 3 ) 3 N + -CH 2 -COO - ).
  • Particularly preferred corresponding compounds have a total molar (betaine + glycine) / Zr ratio of (0.1-3.0): 1, preferably (0.7-1.5): 1, and a betaine molar ratio Glycine of at least 0.001: 1 on.
  • Corresponding compounds are disclosed, for example, in US Pat. No. 7,105,691.
  • the particularly effective antiperspirant salt comprises a so-called "activated" salt, in particular one with a high HPLC peak 5-aluminum content, in particular with a peak 5 surface of at least 33%, particularly preferred at least 45%, based on the total area under peaks 2-5, as measured by HPLC of a 10% by weight aqueous solution of the active substance under conditions in which the aluminum species are resolved into at least 4 consecutive peaks (with peaks 2 - 5).
  • Preferred aluminum zirconium salts having a high HPLC peak 5-aluminum content also referred to as "E 5 AZCH" are disclosed, for example, in US 6436381 and US 6649152.
  • antiperspirant active ingredients are those aluminum zirconium salts having a high HPLC peak 5-aluminum content, which are additionally stabilized with a water-soluble strontium salt and / or with a water-soluble calcium salt.
  • Corresponding salts are disclosed, for example, in US Pat. No. 6,923,952.
  • astringent titanium salts such as disclosed in GB 2299506A.
  • the antiperspirant active compounds can be used as nonaqueous solutions or as glycolic solubilisates.
  • compositions according to the invention are characterized in that the at least one antiperspirant active ingredient in an amount of 5 to 40 wt .-%, preferably 10 to 35% by weight, more preferably 11 to 28% by weight and most preferably 12 to 20% by weight, based on the total weight of the water-free and ligand-free active substance (USP) in the overall composition.
  • USP water-free and ligand-free active substance
  • the antiperspirant active ingredients are preferably used in the formulations according to the invention in an amount of from 1 to 40% by weight, particularly preferably from 3 to 15% by weight, based in each case on the total mass of the preparation, ie including any propellant gases present.
  • the proportion of antiperspirant active ingredients is preferably in the range from 10 to 25% by weight, in each case based on the total mass of the preparation.
  • the composition contains an astringent aluminum salt, in particular aluminum chlorohydrate, more preferably aluminum chlorohydrate with an anhydrous active substance (USP) of 72-88 wt .-%, based on the raw material tel quel.
  • an astringent aluminum salt in particular aluminum chlorohydrate, more preferably aluminum chlorohydrate with an anhydrous active substance (USP) of 72-88 wt .-%, based on the raw material tel quel.
  • Preferred non-activated aluminum chlorohydrates for example, in powder form as Micro Dry ®, Micro Dry ® Ultrafine or Micro Dry ® -323 from Summit Reheis, as Chlorhydrol ® (powder) as well as in activated form as Reach ® 101, Reach ® 103, Reach ® 501 Reheis / Summit or AACH-7171 is sold by Summit. Under the name Reach® 301 an aluminum sesquichlorohydrate from Reheis is offered, which is likewise particularly preferred.
  • Aluminum-zirconium tetrachlorohydrex-glycine complexes for example, from Summit Reheis under the name Rezal ® 36 GP, Summit AZG-369, or Summit AZG-364, or, in activated quality than Summit Reach ® AZP-908 , as powders are on the market.
  • aluminum-zirconium-pentachlorohydrex-glycine complexes which are commercially available, for example, in activated quality from Summit under the designations AAZG-3108 and AAZG-3110.
  • Vicinal diols can also be present as antiperspirant active ingredients in the compositions according to the invention.
  • Preferred vicinal antiperspirant diols are selected from 1,2-propylene glycol, glycerol, 1,2-butylene glycol, 1,2-pentanediol, dipropylene glycol, tripropylene glycol, diglycerol and triglycerol.
  • the total amount of vicinal diols is preferably 10 to 50 wt .-%, more preferably 15% -30%, most preferably 15-25 wt .-%, each based on the total mass of the preparation.
  • compositions according to the invention may contain further antiperspirant active ingredients and / or deodorant active ingredients.
  • preferred deodorant agents which in addition to the at least one silver salt of an organic acid which is selected from aliphatic mono- or dicarboxylic acids having an even number of carbon atoms which may be substituted with one or more hydroxy groups, and aromatic carboxylic acids , can be contained, are odor absorbers, deodorizing ion exchangers, germ-inhibiting agents, prebiotic components and enzyme inhibitors or, more preferably, combinations of said agents.
  • Preferred odor absorbers are, for example, zeolites, Zinkricinoleat, cyclodextrins, certain metal oxides, such as. As alumina, and chlorophyll. They are preferably used in an amount of 0.1-10% by weight, more preferably 0.5-7% by weight and most preferably 1-5% by weight, based in each case on the total composition.
  • germ-inhibiting or antimicrobial active ingredients are understood as meaning those active substances which reduce the number of skin germs participating in the formation of the odor or inhibit their growth. These organisms include, among others, various species from the group of staphylococci, the group of corynebacteria, anaerococci and micrococci.
  • Preferred antimicrobial or antimicrobial agents according to the invention are in particular organohalogen compounds and halides, quaternary ammonium compounds, a number of plant extracts and zinc compounds. These include triclosan, chlorhexidine and chlorhexidine gluconate, 3,4,4'-trichlorocarbanilide, bromochlorophene, dichlorophen, chlorothymol, chloroxylenol, hexachlorophene, dichloro-m-xylenol, dequalinium chloride, domiphenbromide, ammonium phenolsulfonate, benzalkonium halides, benzalkonium cetyl phosphate, benzalkonium saccharinates, benzethonium chloride, Cetylpyridinium chloride, laurylpyridinium chloride, laurylisoquinolinium bromide, methylbenzethonium chloride.
  • phenol phenoxyethanol, di-sodium dihydroxyethylsulfosuccinyl undecylenate, sodium bicarbonate, zinc lactate, sodium phenol sulfonate and zinc phenolsulfonate, ketoglutaric acid, terpene alcohols such as.
  • chlorophyllin copper complexes ⁇ -monoalkyl glycerol ether with a branched or linear saturated or unsaturated, optionally hydroxylated C 6 - C 22 alkyl, particularly preferably ⁇ - (2-ethylhexyl) glycerol ether, commercially available as Sensiva ® SC 50 (ex Schülke & Mayr), carboxylic acid esters of mono-, di- and triglycerol (eg glycerol monolaurate, diglycerol mono- caprinate), lantibiotics and plant extracts (eg green tea and components of lime blossom oil).
  • Sensiva ® SC 50 ex Schülke & Mayr
  • carboxylic acid esters of mono-, di- and triglycerol eg glycerol monolaurate, diglycerol mono- caprinate
  • lantibiotics and plant extracts eg green tea and components of lime blossom oil.
  • deodorant active substances are selected from so-called prebiotic active components, which according to the invention are to be understood as meaning those components which inhibit only or at least predominantly the odor-causing germs of the skin microflora, but not the desired ones, that is to say the non-odor-causing germs belonging to a healthy skin microflora.
  • Coniferous tree extracts in particular from the group of the Pinaceae, and plant extracts from the group of the Sapindaceae, Araliaceae, are explicitly included here.
  • Lamiaceae and Saxifragaceae in particular extracts of Picea spp., Paullinia sp., Panax sp., Lamium album or Ribes nigrum and mixtures of these substances.
  • deodorant active ingredients are selected from the germ-inhibiting active perfume oils and Deosafe ® -Par colmölen that, Haarmann and Reimer, by the company Symrise previously available.
  • the enzyme inhibitors include substances which inhibit the enzymes responsible for the sweat decomposition, in particular arylsulfatase, ⁇ -glucuronidase, aminoacylase, esterases, lipases and / or lipoxigenase, e.g. B. trialkylcitric acid, in particular triethyl citrate, or zinc glycinate.
  • Preferred deodorant or antiperspirant compositions according to the invention are characterized in that the at least one deodorant active ingredient is selected from arylsulfatase inhibitors, ⁇ -glucuronidase inhibitors, aminoacylase inhibitors, esterase inhibitors, lipase inhibitors and lipoxigenase inhibitors.
  • Inhibitors ⁇ -Monoalkylglycerinethern with a branched or linear saturated or unsaturated, optionally hydroxylated C 6 - C 22 - alkyl radical, in particular ⁇ - (2-ethylhexyl) glycerol ether, phenoxyethanol, germ-inhibiting perfume oils, Deosafe ® -Par colmölen (Deosafe ® is a registered Trademark of the company Symrise, formerly Haarmann & Reimer), prebiotic active, trialkylcitric acid esters, especially triethyl citrate, drugs that reduce the number of involved in the formation of odor skin microorganisms from the group of staphylococci, corynebacteria, anaerococci and micrococci or inhibit their growth , Zinc compound compounds, in particular zinc phenolsulfonate and zinc ricinoleate, organohalogen compounds, in particular triclosan, chlorhexidine, chlorhexidine gluconate
  • compositions according to the invention are characterized in that the at least one deodorant active ingredient in a total amount of 0.1 to 10 wt.%, Preferably 0.2 to 7 wt.%, Particularly preferably 0.3 to 5 wt. % and even more preferably 0.4-1.0% by weight, based in each case on the total weight of the active substance of the deodorant active ingredient or of the deodorant active ingredients in the overall composition.
  • Silver acetate has a molecular weight of 166.92 g / mol. Silver has a molecular weight of 107.87 g / mol.
  • Preferred compositions according to the invention are characterized in that silver acetate in a total amount of 1.5-154.7 ppm, preferably 3.1-77.4 ppm, more preferably 7.7-30.9 ppm, most preferably 10.8-15 , 5 ppm, in each case based on the weight of the propellant-free composition of the invention is included.
  • Silver succinate has a molecular weight of 331, 83 g / mol. Silver has a molecular weight of 107.87 g / mol.
  • Preferred compositions according to the invention are characterized in that silver succinate in a total amount of 1.5-153.8 ppm, preferably 3.1-76.9 ppm, more preferably 7.7-30.8 ppm, most preferably 10.8-15.4 ppm, in each case based on the Weight of propellant-free composition of the invention is included.
  • Silver malate has a molecular weight of 347.83 g / mol. Silver has a molecular weight of 107.87 g / mol.
  • Preferred compositions according to the invention are characterized in that silver malate in a total amount of 1.6-161.2 ppm, preferably 3.2-80.6 ppm, more preferably 8.1-32.2 ppm, most preferably 11.3-16 , 1 ppm, in each case based on the weight of the blowing agent-free composition according to the invention is included.
  • Silver tartrate has a molecular weight of 363.83 g / mol.
  • Silver has a molecular weight of 107.87 g / mol.
  • Preferred compositions according to the invention are characterized in that silver tartrate in a total amount of 1.7-168.6 ppm, preferably 3.4-84.3 ppm, more preferably 8.4-33.7 ppm, most preferably 11.8-16 , 9 ppm, in each case based on the weight of the blowing agent-free composition according to the invention is included.
  • Silver adipate has a molecular weight of 353.88 g / mol. Silver has a molecular weight of 107.87 g / mol.
  • Preferred compositions according to the invention are characterized in that silver adipate in a total amount of 1.6-164 ppm, preferably 3.3-82 ppm, more preferably 8.2-32.8 ppm, most preferably 11.5-16.4 ppm, each based on the weight of the propellant-free composition of the invention is included.
  • compositions according to the invention are characterized in that silver galactarate in a total amount of 2 - 196.5 ppm, preferably 3.9 - 98.2 ppm, more preferably 9.8 - 39.3 ppm, most preferably 13.8 - 19.6 ppm, in each case based on the weight of the blowing agent-free composition according to the invention.
  • Silver gluconate has a molecular weight of 303.03 g / mol. Silver has a molecular weight of 107.87 g / mol.
  • Preferred compositions according to the invention are characterized in that silver gluconate in a total amount of 2.8-280.9 ppm, preferably 5.6-140.4 ppm, more preferably 14-56.2 ppm, most preferably 19.7-28.1 ppm, in each case based on the weight of the blowing agent-free composition according to the invention.
  • Silver salicylate has a molecular weight of 244.99 g / mol.
  • Silver has a molecular weight of 107.87 g / mol.
  • Preferred compositions according to the invention are characterized in that silver salicylate in a total amount of 2.3-222.1 ppm, preferably 4.5-113.6 ppm, more preferably 11.4-45.4 ppm, most preferably 15.9-22 , 7 ppm, in each case based on the weight of the blowing agent-free composition according to the invention is included.
  • Silver mandelate has a molecular weight of 259.02 g / mol.
  • Silver has a molecular weight of 107.87 g / mol.
  • compositions according to the invention are characterized in that silver mandelate in a total amount of 2.4-240.1 ppm, preferably 4.8-120 ppm, more preferably 12-48 ppm, most preferably 16.8-24 ppm, in each case based on the Weight of propellant-free composition of the invention is included.
  • compositions according to the invention are characterized in that silver ions in a total amount of 1-100 ppm, preferably 2-50 ppm, more preferably 5-20 ppm, most preferably 7-10 ppm, in each case based on the weight of the propellant-free composition of the invention are.
  • the active substance mixture is equal to the preparation, but if the preparation is an aerosol, the proportions refer to the active mixture without propellant gas.
  • the aerosol compositions according to the invention are preferably prepared by pre-gelling the sheet silicate with an activator in an oil and mixing this gel with a suspension of the carrier oil, preferably cyclopentasiloxane, and a premix of the antiperspirant active and the powdered silver salt. Subsequently, the suspension is filled into a spray can, which is then charged with the desired amount of propellant gas.
  • a suspension of the carrier oil preferably cyclopentasiloxane
  • the stick compositions according to the invention are preferably prepared so that all excipients, in particular the oils, waxes and fatty alcohols, melted and mixed with a premix of talc or phyllosilicate, the antiperspirant active and powdered silver salt and poured liquid into suitable pen sleeves, wherein they antiperspirant sticks solidify.
  • the spray formulations of the present invention are preferably presented from standard aerosol and pen packages.
  • they are suitable for spraying by standard antiperspirant valves and spray heads, as they help prevent clogging disadvantages.
  • the cosmetic and dermatological preparations according to the invention may contain cosmetic adjuvants such as are conventionally used in such preparations, eg. As preservatives, bactericides, UV filters, antioxidants, vitamins, minerals, suspended solid particles, perfumes, substances to prevent foaming, dyes, pigments that have a coloring effect, thickeners, moisturizing and / or moisturizing substances or other conventional Components of a cosmetic or dermatological formulation such as alcohols, polyols, polymers, foam stabilizers or silicone derivatives.
  • a further preferred embodiment of the invention is characterized in that the composition according to the invention or used according to the invention contains at least one monosaccharide having 5 or 6 carbon atoms and / or at least one disaccharide.
  • a particularly preferred embodiment of the invention is characterized in that the monosaccharide having 5 or 6 carbon atoms is selected from glucose, fructose, galactose, arabinose, ribose, xylose, lyxose, allose, altrose, mannose, gulose, idose, talose, fucose and rhamnose , Exceptionally preferred are glucose, galactose, fructose, fucose and rhamnose, in particular glucose and galactose.
  • Another particularly preferred embodiment of the invention is characterized in that the disaccharide is selected from sucrose, lactose and trehalose. Exceptionally preferred are sucrose and lactose, especially lactose.
  • a further particularly preferred embodiment of the invention is characterized in that at least one monosaccharide having 5 or 6 carbon atoms and / or at least one disaccharide in a total amount of 0.001 to 2.0 wt .-%, preferably 0.005 - 1, 0 wt .-% , Particularly preferably 0.01 to 0.5 wt .-% and most preferably 0.03 to 0.1 wt .-%, each based on the total composition is included.
  • compositions according to the invention be in the form of a pin, they preferably contain a lipid or wax matrix comprising at least one lipid or wax component with a melting point> 5O 0 C.
  • waxes of solid to brittle hard consistency coarse to fine crystalline, translucent to opaque, but not glassy, and melt above 50 0 C without decomposition. They are already slightly above the melting point low viscosity and show a strong temperature-dependent consistency and solubility.
  • Preference according to the invention for example, natural vegetable waxes, z. Candelilla wax, carnauba wax, Japan wax, sugarcane wax, ouricoury wax, cork wax, sunflower wax, fruit waxes such as orange waxes, lemon waxes, grapefruit wax, and animal waxes, e.g. Beeswax, shellac wax and spermaceti.
  • it may be particularly preferred to use hydrogenated or hardened waxes.
  • a wax component and chemically modified waxes especially the hard waxes, such as.
  • montan ester waxes hydrogenated jojoba waxes and Sasol waxes used.
  • Synthetic waxes which are also preferable in the invention include, for example, polyalkylene waxes and polyethylene glycol waxes, C 2 oC 4O dialkyl esters of dimer acids, C 30 - 50 alkyl and alkylaryl esters of -Alkylbienenwachs dinner as well as fatty acids.
  • a particularly preferred wax component is selected from at least one ester of a saturated monohydric C 6 -C 6 -alcohol and a saturated Cs-Cs ⁇ -monocarboxylic acid.
  • ester of a saturated monohydric C 6 -C 6 -alcohol and a saturated Cs-Cs ⁇ -monocarboxylic acid also include lactides, the cyclic double esters of ⁇ -hydroxycarboxylic acids of the corresponding chain length.
  • Esters of fatty acids and long-chain alcohols have been found to be particularly advantageous for the composition of the present invention because they give the antiperspirant preparation excellent sensory properties and pen altogether give a high stability.
  • the esters are composed of saturated branched or unbranched monocarboxylic acids and saturated branched or unbranched monohydric alcohols.
  • esters of aromatic carboxylic acids and hydroxycarboxylic acids eg., 12-hydroxystearic acid
  • saturated branched or unbranched alcohols are used according to the invention, provided that the wax component has a melting point> 5O 0 C. It is particularly preferred to choose the wax components from the group of esters of saturated branched or unbranched alkanecarboxylic acids having a chain length of 12 to 24 carbon atoms and the saturated branched or unbranched alcohols having a chain length of 16 to 50 carbon atoms and having a melting point> 50 0 C have.
  • the wax component C 6-36 alkyl stearates and C 8 - 38 stearate -Alkylhydroxystearoyl- C 2 o 4 o-Alkylerucate and cetearyl be advantageous.
  • the wax or the wax components have a melting point> 5O 0 C, preferably> 6O 0 C on.
  • a particularly preferred embodiment of the invention contains as wax component a C 2 oC 4 o-alkyl stearate.
  • This ester is known under the name Kester ® K82H or Kesterwachs ® K80H and is sold by Koster Keunen Inc.. It is the synthetic imitation of the monoester fraction of beeswax and is characterized by its hardness, oil gelability and broad compatibility with lipid components.
  • This wax can be used as a stabilizer and consistency regulator for W / O and O / W emulsions.
  • Kester wax has the advantage that it has an excellent oil gelability even at low concentrations and so does not make the pencil mass too heavy and allows a velvety abrasion.
  • a further particularly preferred embodiment of the invention contains as wax component cetearyl behenate, ie mixtures of cetyl behenate and stearyl behenate.
  • This ester is known under the name Kester ® K62 and is sold by Koster Keunen Inc..
  • lipid or wax components with a melting point> 5O 0 C are the triglycerides of saturated and optionally hydroxylated C 2 - 3 o-fatty acids, such as hardened Triglyce- ridfette (hydrogenated palm oil, hydrogenated coconut oil, hydrogenated castor oil), glyceryl tribehenate (Tribehe- nin) or glyceryl tri-12-hydroxystearate, further synthetic Vollester of fatty acids and glycols or polyols containing 2 - 6 carbon atoms as long as they have a melting point above 50 0 C, for example, preferably C 8 - C 36 acid triglyceride (Syncrowax ® HGL-C).
  • the hydrogenated castor oil as a wax component available for example as a commercial product Cutina ® HR, is particularly preferred.
  • lipid or wax components with a melting point> 5O 0 C are the saturated linear d 4 - C 36 carboxylic acids, in particular myristic acid, palmitic acid, stearic acid and behenic acid and mixtures of these compounds, eg. B. Syncrowax ® AW 1C (C 18 - C 36 fatty acids) or Cutina ® FS 45 (palmitic and stearic acid).
  • Preferred deodorant or antiperspirant sticks according to the invention are characterized in that the lipid or wax component a) is selected from esters from a saturated, monovalent C 16 -C 6 o-alkanol and a saturated Cs-Cs ⁇ -monocarboxylic acid, in particular cetyl behenate, stearyl behenate and C 2 ° C 4 o-alkyl stearate, glycerol triesters of saturated linear C I2 - C 30 carboxylic acids, which may be hydroxylated, candelilla , Carnauba wax, beeswax, saturated linear C 14 - C 36 carboxylic acids and mixtures of the aforementioned substances.
  • esters from a saturated, monovalent C 16 -C 6 o-alkanol and a saturated Cs-Cs ⁇ -monocarboxylic acid in particular cetyl behenate, stearyl behenate and C 2 ° C 4 o-alkyl stearate
  • Particularly preferred lipid or wax component mixtures a) are selected from mixtures of cetyl behenate, stearyl behenate, hardened castor oil, palmitic acid and stearic acid. Further particularly preferred lipid or wax component mixtures a) are selected from mixtures of C 2 -C 4 -alkyl stearate, hardened castor oil, palmitic acid and stearic acid.
  • the lipid or wax component (s) is contained in total in amounts of 4 to 20% by weight, preferably 8 to 15% by weight, based on the total composition.
  • the ester (s) of a saturated monohydric C 6 -C 6 o-alcohol and a saturated Cs-Cs ⁇ -monocarboxylic acid representing the lipid or wax component (s) are / are in amounts of a total of 2-10 wt .-%, preferably 2-6 wt .-%, based on the total composition.
  • compositions according to the invention which are present as a spray or pin preferably comprise further at least one liquid at 2O 0 C oil that is not a fragrance component and no essential oil.
  • Oils preferred according to the invention are selected from branched saturated or unsaturated fatty alcohols having 6 to 30 carbon atoms. These alcohols are also often referred to as Guerbet alcohols, as they are obtainable by the Guerbet reaction.
  • Preferred oils are alcohol Hexyldecanol (Eutanol ® G 16, Guerbitol ® T 16) Octyldodecanol (Eutanol ® G, Guerbitol ® 20) and 2-ethylhexyl alcohol.
  • Other preferred oil components are mixtures of Guerbet alcohols and Guerbet alcohol esters, for example the commercial product Cetiol ® PGL (hexyldecanol and hexyldecyl laurate).
  • preferred oils are selected from the triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C 8 - 3 o-fatty acids.
  • Particularly suitable may be the use of natural oils, for example soybean oil, cottonseed oil, sunflower oil, palm oil, palm kernel oil, linseed oil, almond oil, castor oil, corn oil, olive oil, rapeseed oil, sesame oil, thistle oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil and the like.
  • natural oils for example soybean oil, cottonseed oil, sunflower oil, palm oil, palm kernel oil, linseed oil, almond oil, castor oil, corn oil, olive oil, rapeseed oil, sesame oil, thistle oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil and the like.
  • synthetic triglyceride oils in particular Capric / Caprylic triglycerides, z.
  • Myritol ® 318 Myritol ® 331 (Cognis) or Miglyol ® 812 (Hüls) with unbranched fatty acid residues and glyceryl triisostearin
  • Estol ® GTEH 3609 Uniqema
  • Myritol ® GTEH Cognis
  • diisopropyl adipate di-n-butyl adipate
  • di (2-ethylhexyl) adipate dioctyl adipate
  • particularly preferred oils are selected from the addition products of from 1 to 5 propylene oxide units onto mono- or polyhydric C 8-22 alkanols, such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, eg. B. PPG-2 myristyl ether and PPG-3 myristyl ether (Witconol APM ®).
  • mono- or polyhydric C 8-22 alkanols such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, eg. B. PPG-2 myristyl ether and PPG-3 myristyl ether (Witconol APM ®).
  • Further oil components preferred according to the invention are selected from the esters of linear or branched saturated or unsaturated fatty alcohols having 2 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2 to 30 carbon atoms, which may be hydroxylated.
  • These include, hexyldecyl stearate (Eutanol ® G 16 S), decyl laurate hexyl, isodecyl neopentanoate, isononyl isononanoate, 2-ethylhexyl palmitate (Cegesoft ® C 24) and 2-ethylhexyl stearate (Cetiol ® 868).
  • butyloctanoate diisotridecyl acetate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate, ethylene glycol dioleate and dipalmitate.
  • oil components are selected from the addition products of at least 6 ethylene oxide and / or propylene oxide units of mono- or polyhydric C 3 - 22 -alkanols such as butanol, butanediol, myristyl alcohol and stearyl alcohol, eg. As PPG-14 butyl ether (Ucon Fluid ® AP), PPG-9-butyl ether (Breox B25 ®), PPG-10 butanediol (Macol ® 57) and PPG-15 stearyl ether (Arlamol ® E).
  • PPG-14 butyl ether Ucon Fluid ® AP
  • PPG-9-butyl ether Breox B25 ®
  • PPG-10 butanediol Macol ® 57
  • PPG-15 stearyl ether Arlamol ® E
  • Further oil components preferred according to the invention are selected from the C 8 -C 22 fatty alcohol esters of monohydric or polyhydric C 2 -C 7 -hydroxycarboxylic acids, in particular the esters of glycolic acid, lactic acid, malic acid, tartaric acid, citric acid and salicylic acid.
  • Ci 2 -Ci 5 -alkyllactate and of branched in 2-position Ci 2 / i 3 alkanols are under the trademark Cosmacol ® by the company Nordmann, Rassmann GmbH & Co, Hamburg, refer, in particular the commercial products Cosmacol ® ESI, Cosmacol® ® EMI and Cosmacol® ® EIT.
  • oil components are selected from the symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, eg. B. Glycerincarbo- nat, dicaprylyl carbonate (Cetiol ® CC) or the esters of DE 197 56 454 A1.
  • Further preferred oil components according to the invention are selected from the esters of dimers of unsaturated C 12 -C 22 -fatty acids (dinner fatty acids) with monovalent linear, branched or cyclic C 2 -C 18 -alkanols or with polyvalent linear or branched C 2 -C 6 -alkanols. It may be extraordinarily preferred according to the invention to use mixtures of the abovementioned oils.
  • oil components preferred according to the invention are selected from silicone oils and hydrocarbon oils.
  • Silicone oils which are preferred according to the invention are selected from dialkyl and alkylaryl siloxanes, such as, for example, cyclopentasiloxane, cyclohexasiloxane, dimethylpolysiloxane and methylphenylpoly- siloxane, but also include hexamethyldisiloxane, octamethyltrisiloxane and decamethyltetrasiloxane. Further inventively preferred silicone oils are selected from volatile silicone oils which may be cyclic, such as.
  • octamethylcyclotetrasiloxane for example, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane and dodecamethylcyclohexasiloxane and mixtures thereof, as described for. B. in the commercial products DC 244, 245, 344 and 345 of Dow Corning, or linear, z.
  • hexamethyldisiloxane (L 2 ) octamethyltrisiloxane (L 3 ), decamethyltetrasiloxane (L 4 ), any two and three mixtures of L 2 , L 3 and / or L 4 , as described, for. B.
  • silicone oils are selected from non-volatile higher molecular weight linear dimethylpolysiloxanes, commercially available z.
  • Dow Corning ® 190 Dow Corning ® 200 fluid with viscosities ranging from 5 to 100 cSt, preferably of 5 - 50 cSt or 5 - 10 cSt, and Baysilon ® 350 M.
  • preferred natural and synthetic hydrocarbons are selected from paraffinic oils, isohexadecane, isoeicosane, polyisobutenes and polydecenes, which are obtainable for example under the designation Emery ® 3004, 3006, 3010 or under the name Ethylflo ® of albums aria or Nexbase ® 2004G from Nestle, and 1 , 3-di- (2-ethylhexyl) -cyclohexane (Cetiol ® S).
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that the oil (s) liquid at 20 ° C. in a total amount of 0.1-80% by weight, preferably 2-20% by weight, particularly preferably 3-15% by weight, in each case based on the total weight of the composition, is / are contained.
  • a proportion of the oil components of at least 80 wt .-%, a refractive index n D of 1, 39 - 1, 51 on.
  • Compositions which are particularly preferred according to the invention furthermore preferably contain at least one skin-cooling active substance.
  • Skin-cooling active ingredients suitable according to the invention are, for example, menthol, isopulegol and menthol derivatives, eg. B. menthyl lactate, menthyl glycollate, Menthylpyrrolidoncarbonklare, menthyl methyl ether, menthoxypropanediol, menthone glycerol acetal (9-methyl-6- (1-methylethyl) -1, 4-dioxaspiro (4.5) decane-2-methanol), Monomenthylsuccinat and 2-hydroxymethyl -3,5,5-trimethylcyclohexanol.
  • Preferred skin-cooling active ingredients are menthol, isopulegol, menthyl lactate, menthoxypropanediol and menthylpyrrolidonecarboxylic acid, and mixtures of these substances, in particular mixtures of menthol and menthyl lactate, menthol, menthol glycolate and menthyl lactate, menthol and menthoxypropanediol or menthol and isopulegol.
  • At least one skin-cooling active substance is present in a total amount of 0.01-1% by weight, particularly preferably 0.02-0.5% by weight and extraordinarily preferably 0.05-0.2% by weight, based in each case on the total weight of the composition.
  • compositions according to the invention which are formulated as a propellant-driven aerosol, contain at least one propellant.
  • propellants are propane, propene, n-butane, isobutane, isobutene, n-pentane, pentene, isopentane, isopentene, methane, ethane, dimethyl ether, nitrogen, air, oxygen, nitrous oxide, 1, 1, 1, 3-tetrafluoroethane, heptafluoro-n-propane, perfluoroethane, monochlorodifluoromethane, 1, 1-difluoroethane, both individually and in combination.
  • hydrophilic propellants such.
  • hydrophilic gases can be used advantageously in the context of the present invention, when the proportion of hydrophilic gases is selected low and lipophilic propellant gas (eg., Propane / butane) is present in excess.
  • propellant gas eg., Propane / butane
  • propane, n-butane, isobutane and mixtures of these propellants propane, n-butane, isobutane and mixtures of these propellants. It has been found that the use of n-butane as the only propellant gas according to the invention can be particularly preferred.
  • the amount of blowing agent is preferably 20-80% by weight, more preferably 30-70% by weight and most preferably 40-50% by weight, based in each case on the total weight of the preparation, consisting of the composition according to the invention and the blowing agent.
  • compositions according to the invention also comprise at least one water-soluble polyhydric C 2 -C 9 -alkanol having 2-6 hydroxyl groups and / or at least one water-soluble polyethylene glycol having 3-20 ethylene oxide units and mixtures thereof.
  • These components are preferably selected from 1,2-propylene glycol, 2-methyl-1,3-propanediol, glycerol, butylene glycols such as 1,2-butylene glycol, 1,3-butylene glycol and 1,4-butylene glycol, pentyleneglycols such as 1, 2-pentanediol and 1, 5-pentanediol, hexanediols such as 1,6-hexanediol, hexanetriols such as 1, 2,6-hexanetriol, 1,2-octanediol, 1,8-octanediol, dipropylene glycol, tripropylene glycol, diglycerol, triglycerol, erythritol, Sorbitol and mixtures of the aforementioned substances.
  • Suitable water-soluble polyethylene glycols are selected from PEG-3, PEG-4, PEG-6, PEG-7, PEG-8, PEG-9, PEG-10, PEG-12, PEG-14, PEG-16, PEG-18 and PEG-20 and mixtures thereof, with PEG-3 to PEG-8 being preferred.
  • Preferred deodorant or antiperspirant compositions according to the invention are characterized in that the at least one water-soluble polyvalent C 2 -C 9 -alkanol with 2 to 6 hydroxyl groups and / or at least one water-soluble polyethylene glycol having 3 to 20 ethylene oxide units is selected from 1,2-propylene glycol, 2-methyl-1,3-propanediol, glycerol, butylene glycols such as 1,2-butylene glycol, 1,3 Butylene glycol and 1, 4-butylene glycol, pentylene glycols such as 1, 2-pentanediol and 1, 5-pentanediol, hexanediols such as 1, 6-hexanediol, hexanetriols such as 1, 2,6-hexanetriol, 1, 2-octanediol, 1, 8 -Octandiol, dipropylene glycol, tripropylene glycol, diglycerol, trig
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that the at least one water-soluble polyhydric C 2 -C 9 -alkanol having 2 to 6 hydroxyl groups and / or at least one water-soluble polyethylene glycol having 3 to 20 ethylene oxide units in total amounts of 3 - 30 wt .-%, preferably 8 - 25 wt .-%, particularly preferably 10-18 wt .-%, each based on the total composition, is included.
  • deodorant or antiperspirant compositions are characterized in that at least one lipid or wax component with a melting point in the range of 25 - ⁇ 5O 0 C, selected from Kokosfett Textreglycerinmono- mono-, di- and triesters, Butyrospermum Parkii (Shea Butter ) and esters of saturated, monohydric C 8 -C 18 alcohols with saturated C 12 -C 18 monocarboxylic acids and mixtures of these substances.
  • These lower melting lipid or wax components allow consistency optimization of stick-shaped or creamy products and minimization of visible residue on the skin.
  • Cocoglycerides voltage in particular the commercial products Novata ® (ex Cognis), particularly preferably Novata AB ®, a mixture of C 2 -C 8 mono-, di- and triglycerides, which in the range of 30-32 ° C, as well as the products of the Softisan series (Sasol Germany GmbH) with the INCI name Hydrogenated Cocoglycerides, in particular Softisan 100, 133, 134, 138, 142.
  • 2 -C 8 alcohols with saturated C 2 -C 8 - monocarboxylic acids are stearyl laurate, cetearyl stearate (e.g., Crodamol ® CSS.), Cetyl palmitate (for example Cutina ® CP.) And myristyl myristate (for example Cetiol ® MM). ,
  • deodorant or antiperspirant according to the invention cooperation ratios are characterized in that the at least one lipid or wax component with a melting point in the range of 25 - ⁇ 5O 0 C in amounts of 0.01 to 20 Wt .-%, preferably 3 - 20 wt .-%, more preferably 5 - 18 wt .-% and exceptionally preferably 6-15 wt .-%, based on the total composition, is included.
  • compositions according to the invention which are in the form of sticks, are characterized in that they are used to improve pen sticking.
  • consistency and the sensory properties further comprise at least one solid, water-insoluble particulate filler other than talc and layered silicates.
  • this filler is selected from optionally modified starches (for. Example, of corn, rice, potatoes) and starch derivatives, which are, if desired, pregelatinized, in particular starch derivatives of type DRY FLO ®, cellulose and cellulose derivatives, silica, silicic acids, e.g.
  • Aerosil ® types spherical polyalkylsesquisiloxane particles (especially Aerosil ® R972 and Aerosil ® 200V from Degussa), silica gels, boron nitride, lactoglobulin derivatives, eg.
  • Polymer powder based on a polymethacrylate copolymer are z. B. as a commercial product Polytrap ® 6603 (Dow Corning) available.
  • Other polymer powders e.g. Example based on polyamides, obtainable under the name Orgasol ® 1002 (polyamide-6) and Orgasol ® 2002 (polyamide-12) from Elf Atochem.
  • Other polymer powders which are suitable for the purpose according to the invention are, for. B.
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that they contain at least one solid, water-insoluble particulate filler in a total amount of 0.01 to 30% by weight, preferably 5 to 20% by weight, more preferably 8 to 15 Wt .-%, each based on the total composition included.
  • perfume component perfumes perfume oils or perfume oil ingredients can be used.
  • perfume oils or fragrances can according to the invention individual fragrance compounds, eg. As the synthetic products of the ester type, ethers, aldehydes, ketones, alcohols and hydrocarbons.
  • Fragrance compounds of the ester type are, for example, benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinylacetate (DMBCA), phenylethylacetate, benzylacetate, ethylmethylphenylglycinate, allylcyclohexylpropionate, styrallylpropionate, benzylsalicylate, cyclohexylsalicylate, floramate, melusate and jasmecyclate.
  • DMBCA dimethylbenzylcarbinylacetate
  • the ethers include, for example, benzyl ethyl ether and ambroxane, to the aldehydes, for example, the linear alkanals with 8 - 18 carbon atoms, citral, citronellal, citronellyloxy-acetaldehyde, cyclamen aldehyde, Lilial and Bourgeonal, to the ketones eg the Jonone, alpha-lsomethylionon and Methylcedryl ketone, the alcohols anethole, citronellol, eugenol, geraniol, linalool, phenylethyl alcohol and terpineol; the hydrocarbons mainly include the terpenes such as limonene and pinene.
  • mixtures of different fragrances are used, which together produce an attractive fragrance.
  • perfume oils may also contain natural fragrance mixtures such as are available from vegetable sources, e.g. Pine, citrus, jasmine, patchouly, rose or ylang-ylang oil. Also suitable are Muskateller sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, lime blossom oil, juniper berry oil, vetiver oil, olibanum oil, galbanum oil and labdanum oil and orange blossom oil, neroli oil, orange peel oil and sandalwood oil.
  • a fragrance In order to be perceptible, a fragrance must be volatile, whereby besides the nature of the functional groups and the structure of the chemical compound, the molecular weight also plays an important role. For example, most odorants have molecular weights up to about 200 daltons, while molecular weights of 300 daltons and above are more of an exception.
  • the smell of a perfume or fragrance composed of several fragrances changes during evaporation, whereby the odor impressions in "top note", “middle note or body”
  • the top note of a perfume or fragrance consists not only of volatile compounds, while the base note for the most part from less volatile
  • volatile fragrances can be bound to certain fixatives, which prevents them from evaporating too quickly the odor impression and on whether the corresponding end fragrance is perceived as the head or middle note, nothing said.
  • Adhesion-resistant fragrances which can be used in the context of the present invention are, for example, the essential oils such as angelica root oil, aniseed oil, arnica blossom oil, basil oil, bay oil, bergamot oil, Champacablütenöl, Edel fir oil, Edeltannenzapfen oil, Elemiöl, eucalyptus oil, fennel oil, spruce needle oil, galbanum oil, geranium oil, ginger grass oil, Guaiac wood oil, guriuri balm oil, helichrysum oil, ho oil, ginger oil, iris oil, cajeput oil, calamus oil, chamomile oil, camphor oil, kanga oil, cardamom oil, cassia oil, pine needle oil, copa ⁇ va balsam oil, coriander oil, spearmint oil, cumin oil, cumin oil, lavender oil, lemongrass oil, lime oil, Tangerine oil, Melissa oil, Musk grain oil, Myrrh oil, Clove oil, N
  • fragrances can be used in the context of the present invention as adherent fragrances or fragrance mixtures, ie fragrances.
  • These compounds include the compounds listed below and mixtures thereof: Ambrettolide, alpha-amylcinnamaldehyde, anethole, anisaldehyde, anisalcohol, anisole, methyl anthranilate, acetophenone, benzylacetone, benzaldehyde, ethyl benzoate, benzophenone, benzyl alcohol, benzyl acetate, benzyl benzoate, benzyl formate, benzyl valerate, borneol, bornyl acetate, alpha-bromostyrene, n- Decyl aldehyde, n-dodecyl aldehyde, eugenol, eugenol methyl ether, eucalyptol, far
  • the more volatile fragrances include in particular the lower-boiling fragrances of natural or synthetic origin, which can be used alone or in mixtures.
  • Examples of more volatile fragrances are alkyl isothiocyanates (alkyl mustard oils), butanedione, limonene, linalool, linayl acetate and propionate, menthol, menthone, methyl-n-heptenone, phellandrene, phenylacetaldehyde, terpinyl acetate, citral, citronellal.
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that at least one perfume component is contained in a total amount of 0.00001 to 4 wt .-%, preferably 0.5 to 2 wt .-%, each based on the total composition ,
  • compositions according to the invention are characterized in that at least one perfume component is present in encapsulated form.
  • the capsule material is water-soluble.
  • a preferred water-soluble capsule material is sodium starch octenyl succinate.
  • the perfume capsules are preferably composed of about 40% sodium starch octenyl succinate, 10% mannitol and about 50% perfume oil.
  • the amount of perfume capsules used is preferably in the range from 0.3 to 0.8% by weight, based on the total mass of the preparation. In addition, it is possible to contain 0.8-1.2% by weight of unencapsulated, that is to say free, perfume oil.
  • Preferred constituents of a spray preparation according to the invention are disteardimonium hedetites, aluminum chlorohydrate, perfume and silver acetate, preferably with butane and / or propane as propellant gases.
  • Preferred constituents of a further spray preparation according to the invention are disteardimonium hectorite, aluminum chlorohydrate, perfume and silver gluconate, preferably mixed with butane and / or propane as propellant gases.
  • Preferred constituents of a further spray preparation according to the invention are disteardimonium hectorite, aluminum chlorohydrate, perfume and silver succinate, preferably with butane and / or propane as propellant gases.
  • Preferred constituents of a further spray preparation according to the invention are disteardimonium hectorite, aluminum chlorohydrate, perfume and silver malate, preferably with butane and / or propane as propellant gases.
  • Preferred constituents of a further spray preparation according to the invention are disteardimonium hectorite, aluminum chlorohydrate, perfume and silver acetate, preferably with butane and / or propane as propellant gases.
  • Preferred constituents of a further spray preparation according to the invention are disteardimonium hectorite, aluminum chlorohydrate, perfume and silver adipate, preferably with butane and / or propane as propellant gases.
  • Preferred constituents of a further spray preparation according to the invention are disteardimonium hectorite, aluminum chlorohydrate, perfume and silver bergaractarate, preferably with butane and / or propane as propellant gases.
  • Preferred constituents of a further spray preparation according to the invention are disteardimonium hectorite, aluminum chlorohydrate, perfume and silver salicylate, preferably with butane and / or propane as propellant gases.
  • Preferred constituents of a further spray preparation according to the invention are disteardimonium hectorite, aluminum chlorohydrate, perfume and silver mandelate, preferably with butane and / or propane as propellant gases.
  • Preferred constituents of a stick preparation according to the invention are talc, aluminum chlorohydrate, perfume and silver acetate.
  • Preferred constituents of another stick preparation according to the invention are talc, aluminum chlorohydrate, perfume and silver gluconate.
  • Preferred constituents of another stick preparation according to the invention are talc, aluminum chlorohydrate, perfume and silver succinate.
  • Preferred constituents of another stick preparation according to the invention are talc, aluminum chlorohydrate, perfume and silver malate.
  • Preferred constituents of another stick preparation according to the invention are talc, aluminum chlorohydrate, perfume and silver tartrate.
  • Preferred constituents of another stick preparation according to the invention are talc, aluminum chlorohydrate, perfume and silver adipate.
  • Preferred constituents of another stick preparation according to the invention are talc, aluminum chlorohydrate, perfume and silver bergaractarate.
  • Preferred constituents of another stick preparation according to the invention are talc, aluminum chlorohydrate, perfume and silver salicylate.
  • Preferred constituents of another stick preparation according to the invention are talc, aluminum chlorohydrate, perfume and silver mandelate.
  • a further subject of the present application is a non-therapeutic, cosmetic method for reducing and / or regulating perspiration and / or body odor, in which a composition according to the invention or a preferred composition according to the invention, in particular a composition according to one of claims 1, 2, 3 , 4, 5, 6, 7, 8, 9, 10, 11, 12 or 13 in an effective amount on the skin, preferably on the skin in the underarm area, is applied.
  • a further subject of the present application is the non-therapeutic, cosmetic use of a preferred or an inventively preferred antiperspirant composition according to the invention, in particular a composition according to one of claims 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 or 13 to reduce and / or regulate perspiration and / or body odor.
  • compositions according to the invention applies mutatis mutandis.
  • Table 1 Suspensions for spraying as an antiperspirant spray
  • the antiperspirant suspensions 1.1 to 1.9 were mixed with a butane / isobutane / propane
  • composition of the perfume capsules (amounts in% by weight, based on the total weight of the perfume capsules):

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne une préparation cosmétique ou dermatologique non aqueuse qui contient au moins un sel d'argent d'un acide organique sélectionné parmi les acides monocarboxyliques ou dicarboxyliques aliphatiques possédant un nombre pair d'atomes de carbone, qui peuvent être substitués par un ou plusieurs groupes hydroxy, et les acides carboxyliques aromatiques, en association avec un ou plusieurs agents épaississants sélectionnés dans le groupe des phyllosilicates et/ou du talc, un ou plusieurs actifs anti-transpirants et un parfum.
PCT/EP2010/057207 2009-06-19 2010-05-26 Compositions cosmétiques contenant des sels d'argent sélectionnés WO2010145921A2 (fr)

Applications Claiming Priority (18)

Application Number Priority Date Filing Date Title
DE102009027058 2009-06-19
DE102009027058.2 2009-06-19
DE102009027055 2009-06-19
DE102009027060 2009-06-19
DE102009027060.4 2009-06-19
DE102009027055.8 2009-06-19
DE102009027061.2 2009-06-19
DE102009027059 2009-06-19
DE102009027057.4 2009-06-19
DE102009027062 2009-06-19
DE102009027059.0 2009-06-19
DE102009027062.0 2009-06-19
DE102009027057 2009-06-19
DE102009027061 2009-06-19
DE102009027207 2009-06-25
DE102009027208 2009-06-25
DE102009027208.9 2009-06-25
DE102009027207.0 2009-06-25

Publications (2)

Publication Number Publication Date
WO2010145921A2 true WO2010145921A2 (fr) 2010-12-23
WO2010145921A3 WO2010145921A3 (fr) 2012-05-18

Family

ID=43082083

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2010/057207 WO2010145921A2 (fr) 2009-06-19 2010-05-26 Compositions cosmétiques contenant des sels d'argent sélectionnés

Country Status (1)

Country Link
WO (1) WO2010145921A2 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9554982B2 (en) 2012-09-14 2017-01-31 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US9579265B2 (en) 2014-03-13 2017-02-28 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US9662285B2 (en) 2014-03-13 2017-05-30 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US10758476B1 (en) 2017-09-18 2020-09-01 Type A Brands, Llc Deodorant with sweat-activated technology
US11357714B2 (en) 2020-07-21 2022-06-14 Chembeau LLC Diester cosmetic formulations and uses thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62289512A (ja) * 1986-06-10 1987-12-16 Lion Corp 防臭化粧料
US6444726B1 (en) * 1995-03-14 2002-09-03 Clariant Finance (Bvi) Limited Biocidal compositions
WO2008104310A2 (fr) * 2007-02-27 2008-09-04 Clariant Finance (Bvi) Limited Compositions antimicrobiennes
DE202008014407U1 (de) * 2008-07-08 2009-02-05 Beiersdorf Ag Kosmetische Zubereitungen mit passiviertem Silber

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62289512A (ja) * 1986-06-10 1987-12-16 Lion Corp 防臭化粧料
US6444726B1 (en) * 1995-03-14 2002-09-03 Clariant Finance (Bvi) Limited Biocidal compositions
WO2008104310A2 (fr) * 2007-02-27 2008-09-04 Clariant Finance (Bvi) Limited Compositions antimicrobiennes
DE202008014407U1 (de) * 2008-07-08 2009-02-05 Beiersdorf Ag Kosmetische Zubereitungen mit passiviertem Silber

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9554982B2 (en) 2012-09-14 2017-01-31 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US9554981B2 (en) 2012-09-14 2017-01-31 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US10076489B2 (en) 2012-09-14 2018-09-18 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US10076490B2 (en) 2012-09-14 2018-09-18 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US9579265B2 (en) 2014-03-13 2017-02-28 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US9662285B2 (en) 2014-03-13 2017-05-30 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US10076474B2 (en) 2014-03-13 2018-09-18 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US10758476B1 (en) 2017-09-18 2020-09-01 Type A Brands, Llc Deodorant with sweat-activated technology
US11357714B2 (en) 2020-07-21 2022-06-14 Chembeau LLC Diester cosmetic formulations and uses thereof
US11491092B2 (en) 2020-07-21 2022-11-08 Chembeau LLC Hair treatment formulations and uses thereof
US11801211B2 (en) 2020-07-21 2023-10-31 Chembeau LLC Hair treatment formulations and uses thereof

Also Published As

Publication number Publication date
WO2010145921A3 (fr) 2012-05-18

Similar Documents

Publication Publication Date Title
EP1773454B1 (fr) Stick deodorant ou antitranspirant sans traces a base d'une dispersion huile dans eau
DE102009029423A1 (de) Antibakterielle kosmetische oder pharmazeutische, zur Körperdeodorierung geeignete Zusammensetzungen gegen Körpergeruch
DE102010063250A1 (de) Wasserhaltige Antitranspirant-Zusammensetzungen mit verbesserter Rückstandsmaskierung
DE102009027604A1 (de) Kosmetische Zusammensetzungen mit Suspensionen von Silbersalzen
EP2413889B1 (fr) Sprays anti-transpirants sans eau à libération améliorée de substance active
DE102006040302A1 (de) Antitranspirant- und Deodorant-Zusammensetzungen mit verbesserter Pflegewirkung
DE102005029777A1 (de) Rückstandsarmer Deodorant- oder Antitranspirant-Stift auf Basis einer ethanolhaltigen Öl-in-Wasser-Dispersion
DE102009002097A1 (de) Antitranspirant-Sprays mit Esterölen
EP2665463B1 (fr) Stick antitranspirant ayant une meilleure stabilité à long terme
WO2009101000A2 (fr) Déodorants et/ou antitranspirants à fragrance et à capacité d'absorption d'odeurs à effet renforcé
EP2480192B1 (fr) Anti-transpirants non aérosol sans eau à libération améliorée d'agents
WO2010145921A2 (fr) Compositions cosmétiques contenant des sels d'argent sélectionnés
EP2442780B1 (fr) Compositions cosmétiques contenant du lactate d'argent
DE102008059765A1 (de) Neue Deodorantien und Antitranspirantien mit haarwuchsinhibierender Wirkung
EP2884958B1 (fr) Compositions cosmétiques à libération retardée des actifs
DE102017223179A1 (de) Rückstandsminimierte schweißhemmende Zusammensetzung mit verbessertem Hautgefühl
WO2008080764A1 (fr) Compositions antitranspirantes et désodorisantes de potentiel irritatif réduit
DE102012218233A1 (de) Kosmetische Seifengelstifte mit antibakterieller Wirkung
DE102015224559B4 (de) "Textil schonende Antitranspirant-Zusammensetzungen"
WO2010145922A2 (fr) Compositions anti-transpirantes contenant du citrate d'argent
DE102012215674A1 (de) Deodorantien und/oder Antitranspirantien mit antibakterieller Wirkung
EP2442781B1 (fr) Compositions cosmétiques contenant du sulfate d'argent
DE102005029776A1 (de) Rückstandsarmer Deodorant- oder Antitranspirant-Stift auf Basis einer Öl-in-Wasser-Dispersion
DE102006021780A1 (de) Rückstandsarmer Deodorant- oder Antitranspirant-Stift auf Basis einer ethanolhaltigen Öl-in-Wasser-Dispersion/Emulsion

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10720782

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10720782

Country of ref document: EP

Kind code of ref document: A2